AIDS Treatment News
Kidney, Liver Transplant Study for People With HIV

February 28, 2005

This study of kidney and liver transplantation for persons with HIV, by 19 transplant centers with funding from the U.S. National Institutes of Health, is currently running and is open for new people. Even for patients who do not need a transplant immediately but may need one in the future, it can be important to get into the system now to avoid delays if and when a transplant is necessary. Persons with hepatitis C or hepatitis B are not disqualified and will be considered for this study.

Volunteers must:

  • Meet the criteria for transplantation;

  • Have a T-cell count greater than 100 (liver transplant) or greater than 200 (kidney transplant);

  • Meet HIV viral load criteria depending on which organ is needed;

  • Patients with certain opportunistic infections in the past will be considered, and need to have a T-cell count above 200;

  • Pediatric patients are being enrolled in several centers in cities listed above.


For More Information

Specific site and study information can be found at http://spitfire.emmes.com/study/htr/About_Us/about_us.html (might require Internet Explorer browser), or www.clinicaltrials.gov/.

Related published literature can be found at http://spitfire.emmes.com/study/htr/Useful_Links/useful_links.html.

A poster at the recent Retroviruses conference reported the pilot study results so far: Michelle Roland, M.D., Don Stablein, Laurie Carlson, and others. 1- to 3-year outcomes in HIV-infected liver and kidney transplant recipients. 12th Conference on Retroviruses and Opportunistic Infections, Boston, February 22-25, 2005 [abstract 953].


ISSN # 1052-4207

Copyright 2005 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.


Back to the AIDS Treatment News February 28, 2005 contents page.


This article was provided by AIDS Treatment News
, and is a part of the publication AIDS Treatment News.